| Rosacea
Oracea vs Mirvaso
Side-by-side clinical, coverage, and cost comparison for rosacea.Deep comparison between: Oracea vs Mirvaso with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsMirvaso has a higher rate of injection site reactions vs Oracea based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Mirvaso but not Oracea, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Oracea
Mirvaso
At A Glance
Oral
Daily
Tetracycline-class antibiotic
Topical
Once daily
Alpha-2 adrenergic agonist
Indications
- Rosacea
- Rosacea
Dosing
Rosacea 40 mg once daily in the morning on an empty stomach, preferably at least one hour prior to or two hours after meals, administered orally.
Rosacea Apply a pea-sized amount once daily to each of the five areas of the face (central forehead, chin, nose, each cheek) as a thin layer across the entire face, avoiding the eyes and lips; wash hands after applying.
Contraindications
- Hypersensitivity to doxycycline or any of the other tetracyclines
- Hypersensitivity reaction to any component of MIRVASO topical gel (reactions have included angioedema, urticaria, and contact dermatitis)
Adverse Reactions
Most common (>=1%) nasopharyngitis, diarrhea, hypertension, sinusitis, fungal infection, influenza, aspartate aminotransferase increase, blood pressure increase, anxiety, pain, abdominal pain upper, blood lactate dehydrogenase increase, nasal congestion, abdominal distention, abdominal pain, stomach discomfort, dry mouth, blood glucose increase, back pain, sinus headache, pharyngolaryngeal pain
Serious hepatotoxicity, esophagitis, esophageal ulcerations, renal toxicity (rise in BUN), exfoliative dermatitis, photosensitivity, urticaria, angioneurotic edema, anaphylaxis, anaphylactoid purpura, serum sickness, pericarditis, exacerbation of systemic lupus erythematosus, hemolytic anemia, thrombocytopenia, neutropenia, eosinophilia
Postmarketing pseudotumor cerebri (benign intracranial hypertension), headache, fixed drug eruption, depression, anxiety, suicidal ideation, insomnia, abnormal dreams, hallucination
Most common (>=1%) Erythema, flushing, skin burning sensation, contact dermatitis, dermatitis, skin warmth, paraesthesia, acne, skin pain, blurred vision, nasal congestion
Postmarketing Bradycardia, hypotension, angioedema, hypersensitivity, lip swelling, swollen tongue, throat tightness, urticaria, dizziness, pallor
Pharmacology
Doxycycline is a member of the tetracycline-class of drugs; the plasma concentrations achieved with ORACEA are sub-antimicrobial, and the mechanism of action in the treatment of inflammatory lesions of rosacea is unknown.
Brimonidine is a relatively selective alpha-2 adrenergic agonist; topical application of MIRVASO topical gel may reduce facial erythema through direct vasoconstriction.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Oracea
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (9/12) · Qty limit (10/12)
Mirvaso
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (5/12) · Qty limit (0/12)
UnitedHealthcare
Oracea
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Mirvaso
- Covered on 4 commercial plans
- PA (6/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
Oracea
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (2/3) · Qty limit (2/3)
Mirvaso
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (1/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Oracea.
No savings programs available for Mirvaso.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
OraceaView full Oracea profile
MirvasoView full Mirvaso profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.